Skip to main content

Advertisement

Log in

Experience of severe hypoglycaemia may influence both patient's and physician's subsequent treatment policy of insulin-dependent diabetes mellitus

  • ENDOCRINOLOGY
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Daily insulin doses and HbA1c were studied 0–3 months before and 2–6, 7–11, and 12–16 months after 48 consecutive episodes of severe hypoglycaemia (coma and/or convulsion) in children and adolescents with insulin-dependent diabetes mellitus. After 69% of the attacks, either physicians or patients or both decreased daily insulin doses (for the whole group, mean ± SD: 0–3 months before the episode 0.93 ± 0.20 U/kg vs 2–6 months after 0.84 ± 0.20 U/kg, P < 0.001), which may have worsened the subsequent glycaemic control as evidenced by a significant increase in HbA1c (8.3 ± 1.5% vs 9.1 ± 1.8%, P<0.001, respectively). Physicians decreased the insulin dose even in 14 of the 33 patients with a preventable cause for their hypoglycaemia other than erroneous excess of insulin.

Conclusion Experience of severe hypoglycaemia may worsen the subsequent glycaemic control. This might in part be due to an excessive lowering of daily insulin doses by both physicians as well as patients and their families. Hypoglycaemia management must include intensive education about prevention without compromising diabetes control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 30 September 1997 / Accepted in revised form: 13 February 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tupola, S., Rajantie, J. & Åkerblom, H. Experience of severe hypoglycaemia may influence both patient's and physician's subsequent treatment policy of insulin-dependent diabetes mellitus. Eur J Pediatr 157, 625–627 (1998). https://doi.org/10.1007/s004310050899

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004310050899

Navigation